Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

BACKGROUND: Management of type 2 diabetes with metformin often does not provide adequate glycemic control, thereby necessitating add-on treatment. In a 24-week clinical trial, dapagliflozin, an investigational sodium glucose cotransporter 2 inhibitor, improved glycemic control in patients inadequate...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3606470/
https://ncbi.nlm.nih.gov/pubmed/23425012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-11-43
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items